scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0002-9149(96)00174-9 |
P698 | PubMed publication ID | 8651107 |
P2093 | author name string | Thompson PD | |
Bausserman LL | |||
Dickenson R | |||
Zmunda JM | |||
P2860 | cites work | Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production | Q24601964 |
Lipoprotein(a). A genetic risk factor for premature coronary heart disease | Q35877768 | ||
Effect of testosterone cypionate on postexercise ST segment depression | Q36804813 | ||
The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice. | Q46431843 | ||
Delayed effects of prolonged exercise on serum lipoproteins. | Q51634724 | ||
Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. | Q54202553 | ||
Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. | Q55060303 | ||
Contraceptive efficacy of testosterone-induced azoospermia in normal men | Q55983041 | ||
Origin of Estrogen in Normal Men and in Women with Testicular Feminization* | Q66973397 | ||
Androgens: risks and benefits | Q67691228 | ||
The effect of testosterone aromatization on high-density lipoprotein cholesterol level and postheparin lipolytic activity | Q70699430 | ||
Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations | Q72425096 | ||
Testosterone relaxes rabbit coronary arteries and aorta | Q72533013 | ||
Reduction of lecithin-cholesterol acyltransferase, apolipoprotein D and the Lp(a) lipoprotein with the anabolic steroid stanozolol | Q72824684 | ||
HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels | Q93523688 | ||
Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid | Q93524359 | ||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lipoprotein | Q28350 |
testosterone | Q1318776 | ||
testosterone | Q27863114 | ||
P304 | page(s) | 1244-1247 | |
P577 | publication date | 1996-06-01 | |
P1433 | published in | American Journal of Cardiology | Q2208417 |
P1476 | title | Testosterone decreases lipoprotein(a) in men. | |
P478 | volume | 77 |
Q73476975 | Andropause |
Q74449512 | CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys |
Q34716007 | Common conditions of the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression |
Q38186099 | Critical review of non-statin treatments for dyslipoproteinemia. |
Q73008386 | Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women |
Q43813835 | Effects of androgen manipulation on postprandial triglyceridaemia, low-density lipoprotein particle size and lipoprotein(a) in men. |
Q73875036 | Estrogen agonists/antagonists may down-regulate growth hormone signaling in hepatocytes--an explanation for their impact on IGF-I, IGFBP-1, and lipoprotein(a) |
Q35179025 | Genetic evaluation for coronary artery disease |
Q34669332 | Hormonal influences on lipoprotein(a) metabolism |
Q53594509 | Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. |
Q43199254 | Increased occurrence of marked elevations of lipoprotein(a) in ageing, hypercholesterolaemic men with low testosterone |
Q43744352 | Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis |
Q73215906 | Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients |
Q47987181 | Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men. |
Q80296653 | Relationship between testosterone and erectile dysfunction |
Q37825893 | Sex hormones and lipoprotein(a) concentration |
Q86999417 | Testosterone and insulin resistance in the metabolic syndrome and T2DM in men |
Q38485746 | Testosterone and obesity |
Q34718357 | Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). |
Q90575050 | The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts |